Revenues of Neuraxis, INC from 30 Jun 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Neuraxis, INC annual and quarterly Revenues in USD history and change rate from 30 Jun 2022 to 31 Dec 2024.
  • Neuraxis, INC Revenues for the quarter ending 30 Sep 2023 was $477,460, a 23% decline year-over-year.
  • Neuraxis, INC annual Revenues for 2024 was $2,685,925, a 9.2% increase from 2023.
  • Neuraxis, INC annual Revenues for 2023 was $2,460,049, a 8.4% decline from 2022.
Source SEC data
View on sec.gov
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)

Neuraxis, INC Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,685,925 +$225,876 +9.2% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $2,460,049 -$224,686 -8.4% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $2,684,735 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY

Neuraxis, INC Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $477,460 -$141,345 -23% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $646,021 -$36,560 -5.4% 01 Apr 2023 30 Jun 2023 10-Q 22 Sep 2023 2023 Q2
Q3 2022 $618,805 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $682,581 01 Apr 2022 30 Jun 2022 10-Q 22 Sep 2023 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.